Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFadel Partners Regulatory News (FADL)

Share Price Information for Fadel Partners (FADL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 138.00
Bid: 136.00
Ask: 140.00
Change: 0.00 (0.00%)
Spread: 4.00 (2.941%)
Open: 138.00
High: 138.00
Low: 138.00
Prev. Close: 138.00
FADL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

22 Mar 2024 07:00

RNS Number : 8750H
Fadel Partners Inc.
22 March 2024
 

Fadel Partners, Inc.

 

('FADEL', the 'Company' or, together with its subsidiaries, the 'Group')

 

Grant of Options

 

On 22 March 2024 Ian Flaherty, Chief Financial Officer, was awarded the following options over the Company's common shares of US $0.001 par value each ("Common Shares") under the FADEL 2023 Equity Incentive Plan ("Plan"):

 

Name of PDMR

Number of share options granted

Exercise price

Total number of share options held following this notification

Total number of share options as % of current issued share capital

Ian Flaherty

252,890

GBP£1.44

252,890

1.25%

 

 

The market priced share options granted to Ian Flaherty on 22 March 2024 shall become 25% vested and exercisable on the twelve-month anniversary of the date of grant, 22 March 2025, with the remaining balance of option shares becoming vested and exercisable in 36 equal monthly installments commencing with the month following the twelve-month anniversary of the grant date.

 

In addition, further grants of, in aggregate, 377,312 options over Common Shares have been made to certain employees, also under the Plan.

 

Further to the above grants, the number of options over Common Shares granted under the Plan now represents 7.21% of the Company's current issued share capital. 

 

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").

 

For further information please contact:

Tarek Fadel, Chief Executive Officer

Ian Flaherty, Chief Financial Officer

Via Alma PR 

Cavendish Capital Markets Limited (Nomad & Broker)

020 7220 0500

Jonny-Franklin Adams, Emily Watts, Abigail Kelly (Corporate Finance)

Tim Redfern, Sunila De Silva (ECM)

Alma Strategic Communications

Tel: +44(0)20 3405 0205

Josh Royston

fadel@almastrategic.com

Andy Bryant

Sam Modlin

 

 

 

Details of the transaction are reported in the PDMR notification below:

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Ian Flaherty

2

Reason for the notification

 

a)

Position/status

Chief Financial Officer

 

b)

Initial notification/Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fadel Partners, Inc. 

b)

LEI

2138006CF39FSLKDRZ65

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Grant of options over 252,890 common shares of US $0.001 par value each.

 

ISIN: USU3033R1024

 

c)

Currency

GBP£

d)

Price(s) and volumes(s)

Price(s)

Volume(s)

 

GBP£1.44

252,890

e)

Aggregated information

- Aggregated volume

- Price

 

As above

f)

Date of the transaction

22 March 2024

g)

Place of the transaction

NA (grant of options)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDGGDXISDDGSB
Date   Source Headline
14th Jun 20247:00 amRNSNotice of the postponement of AGM
3rd Jun 20247:00 amRNSNew Contract Wins
23rd May 20247:00 amRNSBoard Observer
10th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
2nd Apr 20247:00 amRNSNotice of Results and Presentation
22nd Mar 20247:00 amRNSGrant of Options
1st Mar 20247:00 amRNSLaunch of LicenSeeâ„¢
26th Feb 20247:00 amRNSDirectorate Change
13th Feb 20247:00 amRNSDirectorate Change
31st Jan 20247:00 amRNSTrading Update
29th Nov 20237:00 amRNSResignation of Non-Executive Director
28th Nov 20237:00 amRNSMello Investor Presentations
27th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results and Investor Presentations
4th Aug 20237:00 amRNSExercise of Warrants and Total Voting Rights
25th Jul 20237:00 amRNSHalf Year Trading Update
21st Jul 20235:49 pmRNSResult of AGM
27th Jun 20237:00 amRNSInvestor Presentation
22nd Jun 20237:00 amRNSFinal Results and Notice of AGM
2nd May 20237:00 amRNSIssuance of Common Shares
20th Apr 20237:00 amRNSChange of Investment Manager/ Holdings in Company
12th Apr 20234:03 pmRNSHolding(s) in Company
11th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.